ArticleOncotarget2016
Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL.
Aviya Goldshtein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleOncotarget2016
Aviya Goldshtein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.